v3.26.1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
License and collaborations revenue $ 755 $ 2,882 $ 2,912 $ 7,252
Operating expenses:        
Research and development 11,207 6,022 21,784 13,975
General and administrative 6,028 5,766 11,972 12,112
Total operating expenses 17,235 11,788 33,756 26,087
Loss from operations (16,480) (8,906) (30,844) (18,835)
Fair value change in instruments measured at fair value 7,174 917 (44,190) 3,722
Financing costs (531) 35 (1,113) (1,337)
Other income, net 1,739 534 2,514 836
Loss before income taxes (8,098) (7,420) (73,633) (15,614)
Benefit (provision) for income taxes 0 0 0 0
Net loss (8,098) (7,420) (73,633) (15,614)
Other comprehensive loss, net of tax 0 0 0 0
Comprehensive loss $ (8,098) $ (7,420) $ (73,633) $ (15,614)
Net loss per share:        
Basic (in dollars per share) $ (0.08) $ (0.12) $ (0.81) $ (0.32)
Diluted (in dollars per share) $ (0.14) $ (0.12) $ (0.81) $ (0.32)
Number of shares used in per share calculations:        
Basic weighted average shares outstanding (in shares) 95,483,280 63,376,392 91,211,050 48,712,124
Diluted weighted average shares outstanding (in shares) 111,384,011 63,376,392 91,211,050 48,712,124